These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1907907

  • 41. [Titration and dosage of gabapentin].
    Arroyo S.
    Rev Neurol; ; 34(3):287-9. PubMed ID: 12022082
    [Abstract] [Full Text] [Related]

  • 42. [Clinical studies on gabapentin in Switzerland].
    Shokry A.
    Praxis (Bern 1994); 1996 Jan 23; 85(4):94-8. PubMed ID: 8578060
    [Abstract] [Full Text] [Related]

  • 43. [Safety and tolerability of gabapentin].
    Viteri C.
    Rev Neurol; 1996 Jan 23; 34(3):292-5. PubMed ID: 12022084
    [Abstract] [Full Text] [Related]

  • 44. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK, Morris HH, Rosenfeld W, Blume WT, Penovich PE, Morrell MJ, Leiderman DB, Crockatt JG, LaMoreaux L, Garofalo E, Pierce M.
    Neurology; 1997 Sep 23; 49(3):739-45. PubMed ID: 9305334
    [Abstract] [Full Text] [Related]

  • 45. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ, McLean MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus L, Bernstein P, Rose-Legatt.
    Seizure; 2000 Jun 23; 9(4):241-8. PubMed ID: 10880282
    [Abstract] [Full Text] [Related]

  • 46. [Gabapentin in children and adolescents with epilepsy].
    Herranz JL.
    Rev Neurol; 2000 Jun 23; 34(4):384-7. PubMed ID: 12022057
    [Abstract] [Full Text] [Related]

  • 47. Gabapentin for drug-resistant partial epilepsy.
    Marson AG, Kadir ZA, Hutton JL, Chadwick DW.
    Cochrane Database Syst Rev; 2000 Jun 23; (2):CD001415. PubMed ID: 10796785
    [Abstract] [Full Text] [Related]

  • 48. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
    Rejdak K, Lipa A, Kaczyński K, Stelmasiak Z, GAB/EPI/IPL.
    Wiad Lek; 2011 Jun 23; 64(2):91-6. PubMed ID: 22026272
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)].
    Rajna P, Szíjártó E.
    Ideggyogy Sz; 2006 Sep 20; 59(9-10):361-72. PubMed ID: 17165379
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy].
    Tomović M, Ilić T, Mihajlović M, Jovicić A.
    Vojnosanit Pregl; 1999 Sep 20; 56(2):151-6. PubMed ID: 10437420
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E, Borusiak P, Boenigk HE.
    Epilepsy Res; 2000 Jan 20; 38(1):27-32. PubMed ID: 10604603
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.